Massachusetts Financial Services’s AstraZeneca AZN Stock Holding History

Massachusetts Financial Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4M	Buy	86,627 +64,383	+289%	+$12.1M	0.01%	705
2026 Q1	$4.39M	Buy	+22,244	New	+$4.29M	﹤0.01%	763
2025 Q2	–	Sell	-19,248	Closed	-$2.83M	–	888
2025 Q1	$2.83M	Buy	19,248 +3,868	+25%	+$560K	﹤0.01%	728
2024 Q4	$2.02M	Buy	15,380 +1,079	+8%	+$151K	﹤0.01%	760
2024 Q3	$2.23M	Buy	14,301 +636	+5%	+$103K	﹤0.01%	729
2024 Q2	$2.13M	Buy	13,665 +5,250	+62%	+$790K	﹤0.01%	741
2024 Q1	$1.14M	Buy	+8,415	New	+$1.11M	﹤0.01%	777

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services's AZN Position: Q2 2026 in Review

Massachusetts Financial Services increased its AstraZeneca (AZN) stake by 289% in Q2 2026, buying an estimated $12.1M and bringing the position to 86,627 shares worth $16.4M. The position accounts for 0.01% of the portfolio, ranked #705.

Massachusetts Financial Services first reported a position in AZN in Q1 2024 and has held it in 7 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Massachusetts Financial Services held 86,627 shares of AstraZeneca worth $16.4M as of Q2 2026.
Massachusetts Financial Services bought 64,383 AstraZeneca shares in Q2 2026, an estimated $12.1M.
AstraZeneca made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #705 holding.
Massachusetts Financial Services first reported a position in AstraZeneca in Q1 2024 and has held it in 7 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.